Search results
A number of insiders bought Seelos Therapeutics, Inc. (NASDAQ:SEEL) stock last year, which is great...
Simply Wall St. via Yahoo Finance· 2 years agoUsually, when one insider buys stock, it might not be a monumental event. But when multiple insiders...
UPDATE 2-Seelos Therapeutics' ALS treatment fails mid-stage study
Reuters via Yahoo Finance· 2 months agoSeelos Therapeutics' experimental ALS drug did not meet the main goal of a mid-stage trial, the company said on Tuesday, the latest study setback in a field littered with clinical failures.
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive via Yahoo Finance· 12 months agoKey Takeaways; Cannabis Sector Tilray plummeted 21% on Friday, after announcing a registered offering of $150 million worth of convertible notes. SNDL reported growth in sales over last year ...
